Eszopiclone Tablets USP 3 Mg

Name: Eszopiclone Tablets USP 3 Mg
Brand: M/S ITRADE EXIM
Price: 250.0 INR
Availability: InStock

Price 250.0 INR/ Vial

Get a Price/Quote

MOQ : 100 Vials

Eszopiclone Tablets USP 3 Mg Specification

Brand Name
Eszopiclone Tablets USP 3 Mg

Dosage Form
Tablets

Indication
for the treatment of insomnia

Packaging Type
blister packs or strips

Life Span
3 years

Origin of Medicine
India

Pacakaging (Quantity Per Box)
100 tablets

Ingredients
Eszopiclone USP (3 mg)

Physical Form
Tablets

Function
Other

Recommended For
treatment of insomnia

Dosage
3mg

Dosage Guidelines
As directed by the physician.

Suitable For
Adults

Quantity
10 tablets Strip

Storage Instructions
between 20 C to 25 C

Eszopiclone Tablets USP 3 Mg Trade Information

Minimum Order Quantity
100 Vials

Delivery Time
10 Week

Packaging Details
Eszopiclone USP 3 mg tablets are typically packaged in blister strips (commonly sold in 10-tablet strips) or packed in bottles of 20 to 90 tablets. The strips are often sold in boxes containing 100 tablets (10 strips of 10).

Eszopiclone Tablets USP 3 Mg About

Description :

Eszopiclone USP 3 mg is a non-benzodiazepine sedative-hypnotic prescribed to treat insomnia. It helps you fall asleep faster and stay asleep longer by calming central nervous system activity.

Eszopiclone USP 3 mg is a dark blue, round, film-coated, oral nonbenzodiazepine hypnotic agent. It is a prescription central nervous system (CNS) depressant used to treat insomnia, specifically helping patients fall asleep faster and stay asleep longer.

Common Side Effects

Unpleasant or unusual taste in the mouth (the most commonly reported side effect)
Morning drowsiness and dizziness
Headache, dry mouth, and mild gastrointestinal upset

Warnings & Precautions

Complex Sleep Behaviors: Boxed warning regarding complex sleep behaviors, which can include sleep-walking, sleep-driving, and preparing/eating food while not fully awake.
Next-Day Impairment: Can reduce alertness and motor coordination the following day. It is cautioned against driving or operating machinery until you know how the medication affects you.
Abuse and Tolerance: It is a Schedule IV controlled substance due to the risk of abuse and physical dependence.
Drug Interactions: Additive drowsiness occurs when combined with alcohol, opioids, antidepressants, or other sedative-hypnotics.
Mental Health & Behavior: Can worsen depression or trigger new, aggressive/agitated behavioral changes.
Special Populations: Elderly patients and those with severe liver impairment should generally not exceed a 2 mg dose, as they face a higher risk of cognitive impairment and falls.